Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05546931 · ClinicalTrials.gov registry record · NA

Mobile Health Program for Rural Hypertension

A NA study of Quality of Life and Adherence, Medication, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
334
Enrollment target
1
Study location

NCT05546931: Recruiting NA study of Quality of Life and Adherence, Medication, sponsored by University of Pittsburgh.

NCT05546931 is a NA study of Quality of Life and Adherence, Medication that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 334 participants, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05546931, a NA study of Quality of Life and Adherence, Medication, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
334 participants
Enrollment target
1
Study location

Study Summary

Hypertension (HTN) is the leading modifiable cause of cardiovascular disease. Rural individuals experience challenges of the rural health divide: geographic distance from providers, social isolation, limited social resources, and high rates of low health literacy. This study evaluates a home-based blood pressure monitoring (HBPM) program that provides longitudinal health education, empathic guidance, monitoring, and adaptable patient-centered coaching to rural individuals. Participants in this study will be randomized to receive (1) HBPM with the intervention; or (2) the control, consisting of HBPM and a smartphone with a general health application (WebMD).

Primary Outcome

Change in home-based systolic and diastolic blood pressure from baseline to 6 months between the intervention and usual care arms.

Interventions

  • BEHAVIORAL Coaching application
  • OTHER WebMD
  • BEHAVIORAL Home-based blood pressure monitoring

Study Locations (1)

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 334 participants
Start Date 2023-09-04
Est. Completion 2027-06
Phase NA
University of Pittsburgh

1,238 total trials

What NCT05546931 shows while recruiting

NCT05546931 is an interventional study that assigns participants to a tested intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap, below the 450-participant average among 107 other Quality of Life trials with a reported enrollment target (26% lower).

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 3 interventions - of which Coaching application is the first listed.

NCT05546931 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05546931 about?

NCT05546931 is a clinical study titled "Mobile Health Program for Rural Hypertension". Hypertension (HTN) is the leading modifiable cause of cardiovascular disease. Rural individuals experience challenges of the rural health divide: geographic distance from providers, social isolation, limited social resources, and high rates of low health literacy. This study evaluates a home-based b...

What is the current status of trial NCT05546931?

This trial is currently recruiting. It is a NA study. The enrollment target is 334 participants. The study started on 2023-09-04. Estimated completion is 2027-06.

What conditions does trial NCT05546931 study?

This clinical trial studies the following conditions: Quality of Life, Adherence, Medication, Hypertension,Essential.

What interventions are being tested in trial NCT05546931?

The interventions under investigation include: Coaching application (BEHAVIORAL), WebMD (OTHER), Home-based blood pressure monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT05546931?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05546931 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05546931's enrollment target sits among peer trials

334 21st of 107 higher than 87 of 107 other Quality of Life trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Quality of Life trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05131672 · 334 participants · NA

    Cast or Operation for Medial Epicondyle Fracture Treatment in Children

  • NCT05131685 · 334 participants · NA

    Distal Radius Interventions for Fracture Treatment

  • NCT05722197 · 334 participants · NA

    Assessment of Emotion Regulation Strategies Used When Suicidal

  • NCT05845333 · 334 participants

    Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05546931, the US trial registry maintained by the National Library of Medicine. NCT05546931 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.